Effect of liver dysfunction on outcome of radioactive iodine therapy for Graves’ disease
Abstract Liver dysfunction is a common complication of Graves’ disease (GD) that may be caused by excessive thyroid hormone (TH) or anti-thyroid drugs (ATDs). Radioactive iodine (RAI) therapy is one of the first-line treatments for GD, but it is unclear whether it is safe and effective in patients w...
Main Authors: | Yuyang Ze, Fei Shao, Xuefeng Feng, Shanmei Shen, Yan Bi, Dalong Zhu, Xiaowen Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-12-01
|
Series: | BMC Endocrine Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12902-022-01242-w |
Similar Items
-
Association between radioactive iodine uptake and neutropenia in untreated Graves’ disease
by: Qian Yang, et al.
Published: (2023-01-01) -
Anaplastic Thyroid Carcinoma Following Radioactive Iodine Therapy for Graves' Disease
by: Sun Hwa Kim, et al.
Published: (2013-03-01) -
Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves’ disease patients
by: Rui-Ting Hu, et al.
Published: (2020-05-01) -
TPO antibody status prior to first radioactive iodine therapy as a predictive parameter for hypothyroidism in Graves’ disease
by: Sébastien Verdickt, et al.
Published: (2023-01-01) -
Secular Trends in Ablation Therapy for Graves’ Disease: An Analysis of a 15-Year Experience at a Tertiary Hospital in South Korea
by: Min Joo Kim, et al.
Published: (2021-04-01)